Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Gets More Good Data with Bone Drug Prolia, but Other Risks Await
Amgen Gets More Good Data with Bone Drug Prolia, but Other Risks Await
Amgen Gets More Good Data with Bone Drug Prolia, but Other Risks Await
Submitted by
admin
on February 10, 2010 - 9:01am
Source:
BNET Pharma
News Tags:
Amgen
Prolia
Novartis
Zometa
denosumab
Headline:
Amgen Gets More Good Data with Bone Drug Prolia, but Other Risks Await
Do Not Allow Advertisers to Use My Personal information
